Steven Gelone
Overview
Steven Gelone received an average of $1M in total compensation, including $451K in salary, at Nabriva Therapeutics AG from 2017 to 2021.
2021Nabriva Therapeutics AGPresident and Chief Operating Officer
2020Nabriva Therapeutics AGPresident and Chief Operating Officer
2019Nabriva Therapeutics AGPresident and Chief Operating Officer
2018Nabriva Therapeutics AGPresident and Chief Operating Officer
2017Nabriva Therapeutics AGChief Scientific Officer
Source: SEC filings on July 11, 2022, June 25, 2020, June 14, 2019, and June 19, 2018.
Related executives
We found eight more executives who work or worked at Nabriva Therapeutics AG.
Theodore Schroeder
Nabriva Therapeutics AG
Chief Executive Officer
Daniel Dolan
Nabriva Therapeutics AG
Chief Financial Officer
Jennifer Schranz
Nabriva Therapeutics AG
Chief Medical Officer
Colin Broom
Nabriva Therapeutics AG
Chief Executive Officer
Francesco Lavino
Nabriva Therapeutics AG
Chief Commercial Officer
Elyse Seltzer
Nabriva Therapeutics AG
Chief Medical Officer
Gary Sender
Nabriva Therapeutics AG
Chief Financial Officer
Peter Wolf
Nabriva Therapeutics AG